Robert Lisicki

EVP, Chief Commercial Officer, Arena Pharmaceuticals.

Companies

Zura Bio LtdBoard member Dec 11, 2024 to now¹
Cadrenal Therapeutics, Inc.Board member Jul 24, 2023 to now²
Zura Bio LtdChief executive officer Jun 21, 2024 to Jan 23, 2026³
Zura Bio LtdOfficer Jan 8, 2024 to Jan 26, 2024⁴
Arena PharmaceuticalsEVP, Chief Commercial Officer Jun 20, 2019 to Mar 11, 2022⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arena Pharmaceuticals ARNA0 shares⁶Mar 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 11, 2022Other 21,462 shares of Arena Pharmaceuticals⁶
Mar 11, 2022Other 6,660 shares of Arena Pharmaceuticals⁶
Mar 11, 2022Other 9,441 shares of Arena Pharmaceuticals⁶
Jan 3, 2022Granted 21,462 shares of Arena Pharmaceuticals⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZura Bio Ltd, Board member
2
SEC EDGARCadrenal Therapeutics, Inc., Board member
3
SEC EDGARZura Bio Ltd, Chief executive officer
4
SEC EDGARZura Bio Ltd, Officer
5
SEC EDGARArena Pharmaceuticals, EVP, Chief Commercial Officer
6
SEC EDGARArena Pharmaceuticals shares after the filing of Mar 11, 2022
7
SEC EDGARForm 4 filed Jan 5, 2022